Back

Anatomical Optimization of renal denervation: Have we found the “sweet spot”?

31 August 2015 (12:51 - 13:01)
Organised by:
Congress Presentation Part of: Renal denervation (RDN) for uncontrolled hypertension: introducing the SPYRAL HTN global clinical trial program Renal denervation Open Access ESC Congress 2015

About the speaker

Photo
Professor Felix Mahfoud

University Hospital Basel, Basel (Switzerland)

5 More presentations in this session

Presentation thumbnail
Brief history of RDN.
Professor F. Mahfoud (Basel, CH)
Slides
Presentation thumbnail
Addressing the confounding effect of dynamic drug therapy adherence in clinical trial design.
Professor P. Blankestijn (Utrecht, NL)
Slides
Presentation thumbnail
Population variability: have we identified the correct population for renal denervation therapy?
Doctor J. Davies (London, GB)
Slides
Presentation thumbnail
Blood pressure measurement: how does the decline translate to CV risk reduction?
Professor G. Mancia (Milan, IT)
Slides
Presentation thumbnail
Introducing the SPYRAL HTN global clinical program and audience Q&A.
Professor M. Boehm (Homburg, DE)
Slides

Access the full session

Session thumbnail
Renal denervation (RDN) for uncontrolled hypertension: introducing the SPYRAL HTN global clinical trial program

The Event

Event poster

ESC Congress 2015

31 August 2015 12:51 CET

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources